Analysis of Early Out-of Hospital Mortality after Transcatheter Aortic Valve Implantation among Patients with Aortic Stenosis Successfully Discharged from the Hospital and Alive at 30 days (From the PARTNER Trial)

N. Beohar,A. Zajarías,V. Thourani,H. Herrmann,M. Mack,S. Kapadia,P. Green,S. Arnold,D. Cohen,P. Généreux,Ke Xu,M. Leon,A. Kirtane

2015-01-01

Abstract:In high risk/inoperable patients with severe symptomatic aortic stenosis, transcatheter aortic valve implantation (TAVI) is a proven alternative to standard (i.e., medical) therapy (ST) or surgical AVR. Concerns have been raised, however, about patients who survive the procedure but have a short subsequent survival. We therefore sought to identify correlates of early out-of-hospital mortality (EOHM) among patients undergoing successful TAVI, rendering TAVI potentially “futile”. Patients who were discharged from the hospital and survived >30 days but <12 months after TAVI were identified (EOHM group). Independent predictors of EOHM were explored, including patient-level factors and procedural non-fatal major complications (NFMC). A sensitivity analysis was also performed excluding patients with NFMC. Among 485 patients who were discharged from the hospital and survived 30 days following TAVI, 101 (21%) were dead Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. within one year. Independent predictors of EOHM included serum creatinine, liver disease, coagulopathy, mental status, body mass index, male gender, and STS score. Although NFMC were strongly associated with EOHM, patient-level risk factors for EOHM were similar among patients who did and did not experience NFMC. Compared to ST, TAVI patients with EOHM had similar 6-month 6-minute walk distance & functional class, with higher rates of repeat hospitalization. In conclusion, among high risk/inoperable patients undergoing TAVI who were discharged and alive at 30 days, EOHM was not infrequent, and was largely determined by presenting characteristics and the occurrence of peri-procedural NFMC. Careful screening and minimization of NFMC may maximize the benefit of TAVI.